Skip to main navigation

Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Charles River logo on side of building
Investor Relations
  • Investor Relations Home
  • Corporate Governance
  • Corporate Citizenship
  • Investor Day 2023
  • Annual Meeting 2026
  • Stock Information
  • News Releases
  • Financial Information
  • SEC Filings
  • Presentations
  • Analyst Information
  • Calendar
  • Shareholder Services

Governance Overview

Corporate Governance
  • Governance Overview
  • Management Team
  • Board of Directors
  • Committee Composition
  • Contact Lead Director
Committee Charters
Audit Committee
Compensation Committee
Corporate Governance and Nominating Committee
Governance Documents
Guidelines
Code of Business Conduct and Ethics
Minimum Stock Ownership
Related Person Transaction Policy 213.4 KB
Compliance Policies
Notice to Former Shareholders of Celsis International Ltd. 14.6 KB
2026 NHP Board Report 1 MB
Investor Relations
  • Investor Relations Home
  • Corporate Governance
  • Corporate Citizenship
  • Investor Day 2023
  • Annual Meeting 2026
  • Stock Information
  • News Releases
  • Financial Information
  • SEC Filings
  • Presentations
  • Analyst Information
  • Calendar
  • Shareholder Services

Stock Quote

(common)
Price
Change (%)
 
Volume
Exchange
Data as of 05/06/26 6:02 pm EDT
Data Provided by Refinitiv.
Minimum 15 minutes delayed.

Featured Reports

2025 Annual Report
View PDF
Print PDF

Charles River Corporate Citizenship Report
View PDF
Print PDF

Toolkit

  • Print Page
  • Email Page
  • RSS Feeds
  • Email Alerts
  • IR Contacts